William Ashton
Director · Medicus Pharma Ltd.
- 2025
- Jun 4, 2026
- 3
Other insiders active in the same sector
No other insider has filed at William Ashton's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Michael Benkowitz - $116.22M in UTHR purchases and sales in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $115.00M in HTFL purchases and sales in the last 12 months
- Michael Simanovsky - $110.65M in SNDA purchases and sales in the last 12 months
- Mayukh Sukhatme - $109.13M in ROIV purchases and sales in the last 12 months
- TCO GROUP HOLDINGS, L.P. - $106.38M in INNV purchases and sales in the last 12 months
- IGNITE AGGREGATOR LP - $106.38M in INNV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is William Ashton?
William Ashton is a corporate insider, tracked as Director of Medicus Pharma Ltd. (MDCX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did William Ashton last file a Form 4?
The most recent primary Form 4 on record is dated 4 June 2026, one of 3 filings going back to 2025.